BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Junior JFCR, Silva AS, Cardoso GA, Silvino VO, Martins MCC, Santos MAP. Androgenic-anabolic steroids inhibited post-exercise hypotension: a case control study. Braz J Phys Ther 2018;22:77-81. [PMID: 28743567 DOI: 10.1016/j.bjpt.2017.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Júnior JFCR, Silva AS, Cardoso GA, Silvino VO, Veras-Silva AS, Nakamura FY, Dos Santos MAP. Differences in Nervous Autonomic Control in Response to a Single Session of Exercise in Bodybuilders Using Anabolic Androgenic Steroids. J Hum Kinet 2021;80:93-101. [PMID: 34868420 DOI: 10.2478/hukin-2021-0110] [Reference Citation Analysis]
2 Gomes Gonçalves e Silva DC, Bavaresco Gambassi B, Dantas MGB, Lima-oliveira J, Vieira de Carvalho SL, Morais PADO, Sá CA, Cotrim HP, Santos AM, Sobral Filho DC, Schwingel PA. Excessive dietary supplement use and blood pressure among Brazilian male resistance training practitioners and bodybuilders. Journal of Substance Use 2019;24:619-25. [DOI: 10.1080/14659891.2019.1640302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Sessa F, Salerno M, Di Mizio G, Bertozzi G, Messina G, Tomaiuolo B, Pisanelli D, Maglietta F, Ricci P, Pomara C. Anabolic Androgenic Steroids: Searching New Molecular Biomarkers. Front Pharmacol 2018;9:1321. [PMID: 30524281 DOI: 10.3389/fphar.2018.01321] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
4 Liu JD, Wu YQ. Anabolic-androgenic steroids and cardiovascular risk. Chin Med J (Engl) 2019;132:2229-36. [PMID: 31478927 DOI: 10.1097/CM9.0000000000000407] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]